11.06.2013 22:05 Uhr, Quelle: Wallstreet online

DGAP-Adhoc: Teprotumumab Restarts Clinical Development in New Indication

Genmab A/S 11.06.2013 21:54 Dissemination of a Adhoc News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this …

Weiterlesen bei Wallstreet online